Matrix Capital Management Company, LP
In its 13F for Q2 2025 (holdings as of June 30, 2025, filed August 14, 2025), Matrix Capital Management Company, LP reported 4 stock positions worth $222.8 million. Its top holding was Globalfoundries (GFS) at 59.6% of the portfolio, followed by Aura Biosciences (AURA, 19.5%) and Maze Therapeutics (MAZE, 13.7%). Compared with Q1 2025, it reduced 1. The biggest sale was Globalfoundries (GFS, shares −50%).
- Most Recent 13F
- Q2 2026
- Location
- Portsmouth, NH
- CIK
- 0001410830
- Portfolio Value
- $222.8M (Q2 2025)
- SEC Filing
- 0001172661-25-003340 ↗ filed Aug 14, 2025
Holdings Value
Holdings 4 stocks · $222.8M
Portfolio Sells Q1 2025 → Q2 2025
| GFS Globalfoundries Inc. | Reduce -50.1% | 59.59% | −14.45 |
Portfolio Buys Q1 2025 → Q2 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 0 | $0 | |
| Q1 2026 | 1 | $46.3M | AURA |
| Q4 2025 | 2 | $57.6M | AURA, MAZE |
| Q3 2025 | 3 | $106.7M | MAZE, AURA, ZNTL |
| Q2 2025 | 4 | $222.8M | GFS, AURA, MAZE, ZNTL |
| Q1 2025 | 4 | $347.2M | GFS, AURA, MAZE, ZNTL |
| Q4 2024 | 5 | $2.2B | ALTR, GFS, PRM, AURA, ZNTL |
| Q3 2024 | 7 | $2.1B | ALTR, GFS, PRM, AURA, ZNTL |
| Q2 2024 | 23 | $13.1B | NVDA, QCOM, TDG, ALTR, MRVL |
| Q1 2024 | 23 | $10.8B | NVDA, TDG, QCOM, ALTR, MRVL |